Figure 2From: Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells Parallel screening of drugs from the Johns Hopkins Chemical Compound Library (JHCCL) as TRAIL sensitizers. PC3-TR cells were first incubated with drug treatments (20 μM) for 24 hours after which time the media was removed, refreshed and cells were treated with TRAIL (10 ng/mL) for an additional 24 hrs.Back to article page